| Joel D Orevillo, MD | |
|
7200 Cathedral Rock Dr Ste 170, Las Vegas, NV 89128-0466 | |
| (702) 387-5101 | |
| (702) 382-5675 |
| Full Name | Joel D Orevillo |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 7200 Cathedral Rock Dr Ste 170, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265476774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 10862 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sahara Home Healthcare, Inc | Las vegas, NV | Home health agency |
| Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
| North Vista Hospital | North las vegas, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Associates Inc | 8729989074 | 24 |
News Archive
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Researchers have discovered that secondary infection with the Methicillin-resistant Staphylococcus aureus (MRSA) bacterium (or "superbug") often kills influenza patients because the flu virus alters the antibacterial response of white blood cells, causing them to damage the patients' lungs instead of destroying the bacterium.
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
Keystone Symposia on Molecular and Cellular Biology is pleased to announce it has received a grant from the Alfred P. Sloan Foundation for a unique Advanced Life Sciences Training Program.
› Verified 3 days ago
| Entity Name | Pulmonary Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952436115 PECOS PAC ID: 8729989074 Enrollment ID: O20040119000593 |
News Archive
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Researchers have discovered that secondary infection with the Methicillin-resistant Staphylococcus aureus (MRSA) bacterium (or "superbug") often kills influenza patients because the flu virus alters the antibacterial response of white blood cells, causing them to damage the patients' lungs instead of destroying the bacterium.
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
Keystone Symposia on Molecular and Cellular Biology is pleased to announce it has received a grant from the Alfred P. Sloan Foundation for a unique Advanced Life Sciences Training Program.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel D Orevillo, MD Po Box 81345, Las Vegas, NV 89180-1345 Ph: (702) 384-5101 | Joel D Orevillo, MD 7200 Cathedral Rock Dr Ste 170, Las Vegas, NV 89128-0466 Ph: (702) 387-5101 |
News Archive
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Researchers have discovered that secondary infection with the Methicillin-resistant Staphylococcus aureus (MRSA) bacterium (or "superbug") often kills influenza patients because the flu virus alters the antibacterial response of white blood cells, causing them to damage the patients' lungs instead of destroying the bacterium.
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
Keystone Symposia on Molecular and Cellular Biology is pleased to announce it has received a grant from the Alfred P. Sloan Foundation for a unique Advanced Life Sciences Training Program.
› Verified 3 days ago
Dr. Arshi A. Quadeer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |